Vaping should be ‘promoted’ as smoking cessation aid

Vaping should be ‘promoted’ as smoking cessation aid

October 17 2017 Electronic cigarettes should be promoted as a method of stopping smoking, the...

MHRA issues Drug Safety Updates for loperamide and miconazole

MHRA issues Drug Safety Updates for loperamide and miconazole

October 4 2017 The medicines regulator, the MHRA, has issued Drug Safety Updates on two...

Leo withdraws plans to launch OTC version of Dovonex

Leo withdraws plans to launch OTC version of Dovonex

September 20 2017 Leo Pharma has announced it will not now launch an over-the-counter version of...

Boots introduces generic levonorgestrel for EHC service

Boots introduces generic levonorgestrel for EHC service

September 4 2017 Boots has announced it is starting to make available a cheaper generic...

Which? challenges effectiveness, variety and cost of branded OTC medicines

Which? challenges effectiveness, variety and cost of branded OTC medicines

August 29 2017 Which? has published an article questioning the effectiveness of some over the...

  • Vaping should be ‘promoted’ as smoking cessation aid

    Vaping should be ‘promoted’ as smoking cessation aid

    Tuesday, 17 October 2017 14:31
  • MHRA issues Drug Safety Updates for loperamide and miconazole

    MHRA issues Drug Safety Updates for loperamide and miconazole

    Wednesday, 04 October 2017 16:25
  • Leo withdraws plans to launch OTC version of Dovonex

    Leo withdraws plans to launch OTC version of Dovonex

    Wednesday, 20 September 2017 14:11
  • Boots introduces generic levonorgestrel for EHC service

    Boots introduces generic levonorgestrel for EHC service

    Monday, 04 September 2017 15:09
  • Which? challenges effectiveness, variety and cost of branded OTC medicines

    Which? challenges effectiveness, variety and cost of branded OTC medicines

    Tuesday, 29 August 2017 15:16

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

MHRA1March 21 2016

A consultation on changing the legal category of Ibuprofen Seven Plus 200mg/5ml Oral Suspension from prescription only medicine (POM) to pharmacy only (P) is underway.

Ibuprofen 100mg/5ml suspension is available without prescription, but the Commission on Human Medicines has now advised that a 200mg/5ml strength can be made available as a P medicine.

Setting out its proposals, the medicines regulator, the MHRA, has flagged up a potential risk of confusion over the different strengths as no other OTC ibuprofen 200mg/5ml preparations are available at the moment. “The risk is that a parent/carer, who may be used to giving quantities of suspension suitable for the 100mg/5ml product, might give twice the dose to a child if they give the same amount of this product,” says the consultation document ARM 91.

To address this concern, “the company has proposed appropriate risk minimisation measures to manage the risk of confusion. This will be done by clear warnings on the leaflet and label, and by adding the words, ‘double strength’ clearly highlighted to the outer box and to the label on the bottle itself.

“Additionally, as a P medicine, this product will be supplied only from pharmacies under the supervision of a pharmacist and therefore pharmacy staff can provide additional advice on correct use.”

Ibuprofen Seven Plus 200mg/5ml Oral Suspension is made by Pinewwood Laboratories, and is licensed for rheumatic or muscular pain, headache, dental pain, feverishness, symptoms of cold and influenza in children aged 7-12 years.

The consultation runs until April 4.

Links:

MHRA announcement

MHRA ARM 91 consultation document

OTC News

October 20 2017 The Royal Pharmaceutical Society is calling for the government to provide pharmacists with state-backed indemnity cover, along the lines being proposed for GPs.
December 7 2015 Pharmacists in Scotland have been asked to share their views on what politicians need to be made aware of ahead of the Scottish Parliament elections in 2016. The Royal Pharmaceutical Society...